• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Technetium-99m tetrofosmin and technetium-99m sestamibi imaging of multiple metastases from differentiated thyroid carcinoma.

作者信息

Kosuda S, Yokoyama H, Katayama M, Yokokawa T, Kusano S, Yamamoto O

机构信息

Department of Radiology, National Defense Medical College, Japan.

出版信息

Eur J Nucl Med. 1995 Oct;22(10):1218-20. doi: 10.1007/BF00800609.

DOI:10.1007/BF00800609
PMID:8542909
Abstract

A 79-year-old male with follicular thyroid carcinoma metastasizing to the lung, bone and lymph nodes was subjected to whole-body scintigraphy using technetium-99m tetrofosmin and 99mTc-sestamibi. Both agents delineated the metastatic lesions and the two image qualities were comparable. We believe that 99mTc-tetrofosmin and 99mTc-sestamibi images may be helpful in localizing metastatic foci and substitute for thallium-201 in the follow-up of patients with differentiated thyroid carcinoma.

摘要

相似文献

1
Technetium-99m tetrofosmin and technetium-99m sestamibi imaging of multiple metastases from differentiated thyroid carcinoma.
Eur J Nucl Med. 1995 Oct;22(10):1218-20. doi: 10.1007/BF00800609.
2
The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.非特异性示踪剂在分化型甲状腺癌随访中的应用：锝-99m 替曲膦全身闪烁扫描的结果
Acta Med Austriaca. 1996;23(1-2):69-75.
3
Technetium-99m-tetrofosmin whole-body scintigraphy in the follow-up of differentiated thyroid carcinoma.锝-99m-替曲膦全身闪烁扫描在分化型甲状腺癌随访中的应用
J Nucl Med. 1997 Mar;38(3):348-52.
4
Thallium-201, technetium-99m-tetrofosmin and iodine-131 in detecting differentiated thyroid carcinoma metastases.铊-201、锝-99m-替曲膦和碘-131在检测分化型甲状腺癌转移灶中的应用
J Nucl Med. 1998 Nov;39(11):1897-902.
5
Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.甲状腺球蛋白、低剂量碘-131和锝-99m-替曲膦全身闪烁扫描在分化型甲状腺癌中的应用
J Nucl Med. 1998 May;39(5):870-5.
6
Tc-99m MIBI scintigraphic detection of metastatic insular thyroid carcinoma.锝-99m甲氧基异丁基异腈闪烁扫描术检测转移性甲状腺岛状癌
Clin Nucl Med. 1995 Jan;20(1):31-6. doi: 10.1097/00003072-199501000-00008.
7
Evaluation of technetium-99m-MIBI scintigraphy in metastatic differentiated thyroid carcinoma.
J Nucl Med. 1997 Mar;38(3):352-6.
8
Comparison of 99Tcm-tetrofosmin with 201Tl and 131I in the detection of differentiated thyroid cancer metastases.99锝-替曲膦与201铊和131碘在分化型甲状腺癌转移灶检测中的比较。
Nucl Med Commun. 2000 Oct;21(10):917-23. doi: 10.1097/00006231-200010000-00005.
9
Technetium-99m tetrofosmin uptake in insular thyroid carcinoma. A comparison with iodine-131.
Clin Nucl Med. 2003 May;28(5):385-8. doi: 10.1097/01.RLU.0000063411.38040.92.
10
Value of combined technetium-99m hydroxy methylene diphosphonate and thallium-201 imaging in detecting bone metastases from thyroid carcinoma.锝-99m亚甲基二膦酸盐与铊-201联合显像在检测甲状腺癌骨转移中的价值。
Thyroid. 1997 Oct;7(5):705-12. doi: 10.1089/thy.1997.7.705.

引用本文的文献

1
Use of Tc-sestamibi SPECT/CT when conventional imaging studies are negative for localizing suspected recurrence in differentiated thyroid cancer: a method and a lesson for clinical management.当常规影像学检查对分化型甲状腺癌可疑复发病灶的定位呈阴性时使用 Tc-sestamibi SPECT/CT：一种方法和临床管理的经验教训。
Endocrine. 2018 Oct;62(1):57-63. doi: 10.1007/s12020-018-1636-y. Epub 2018 May 24.
2
Evaluation of thyroid nodules with technetium-99m tetrofosmin dual-phase scintigraphy.用锝-99m 替曲膦双期闪烁扫描术评估甲状腺结节
Eur J Nucl Med. 1997 Jul;24(7):716-21. doi: 10.1007/BF00879657.

本文引用的文献

1
Technetium-99m-tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging.锝-99m-替曲膦作为一种用于心肌灌注显像的新型放射性药物。
J Nucl Med. 1993 Feb;34(2):222-7.
2
Technetium-99m-1,2-bis[bis(2-ethoxyethyl) phosphino]ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent.锝-99m-1,2-双[双(2-乙氧基乙基)膦基]乙烷：一种新型心肌灌注显像剂的人体生物分布、剂量学及安全性
J Nucl Med. 1993 Jan;34(1):30-8.
3
Tc-99m sestamibi and other agents in the detection of metastatic medullary carcinoma of the thyroid.
Clin Nucl Med. 1993 Aug;18(8):657-61. doi: 10.1097/00003072-199308000-00005.
4
Differentiation of single solid lesions in the lungs by means of single-photon emission tomography with technetium-99m methoxyisobutylisonitrile.
Eur J Nucl Med. 1993 Mar;20(3):249-54. doi: 10.1007/BF00170007.
5
Thallium-201 versus technetium-99m-MIBI SPECT in evaluation of childhood brain tumors: a within-subject comparison.
J Nucl Med. 1993 Jul;34(7):1045-51.
6
Tc-99m sestamibi uptake by cerebellar metastasis from bronchogenic carcinoma.
Clin Nucl Med. 1993 Oct;18(10):887-90. doi: 10.1097/00003072-199310000-00013.
7
Comparison of technetium-99m-Q3 and thallium-201 for detection of coronary artery disease in humans.
J Nucl Med. 1994 Apr;35(4):580-6.
8
Tc-99m MIBI brain SPECT in the diagnosis of recurrent glioma.锝-99m 甲氧基异丁基异腈脑单光子发射计算机断层扫描在复发性神经胶质瘤诊断中的应用
Clin Nucl Med. 1994 Jan;19(1):57-8. doi: 10.1097/00003072-199401000-00015.
9
Simultaneous gallium-67 citrate and technetium-99m sestamibi SPET in a case of myocardial lymphoma: comparison with echocardiography before and after chemotherapy.
Eur J Nucl Med. 1994 Sep;21(9):1013-6. doi: 10.1007/BF00238129.
10
Human biodistribution, dosimetry and clinical use of technetium(III)-99m-Q12.
J Nucl Med. 1994 Oct;35(10):1571-80.